CC
REGN icon

Coastland Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Coastland Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-9,400
Closed -$3.39M – 156
2014
Q3 		$3.39M Sell
9,400
-25,400
-73% -$8.51M 0.12% 97
2014
Q2 		$9.83M Buy
34,800
+11,600
+50% +$3.44M 0.51% 55
2014
Q1 		$6.97M Buy
+23,200
New +$7.15M 0.28% 74

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Coastland Capital's REGN Position: Q4 2014 in Review

Coastland Capital sold out of Regeneron Pharmaceuticals (REGN) in Q4 2014, closing a stake of 9,400 shares — an estimated $3.39M sold.

Coastland Capital first reported a position in REGN in Q1 2014 and held it in 3 quarters. The position peaked at $9.83M in Q2 2014. 511 funds tracked by Wall St. Rank hold REGN as of Q4 2014.

  • Coastland Capital reported no remaining Regeneron Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Coastland Capital sold 9,400 Regeneron Pharmaceuticals shares in Q4 2014, an estimated $3.39M.
  • Coastland Capital first reported a position in Regeneron Pharmaceuticals in Q1 2014 and held it in 3 quarters.
  • Coastland Capital's Regeneron Pharmaceuticals position peaked at $9.83M in Q2 2014.
  • 511 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2014.

Based on Coastland Capital's 13F filing for Q4 2014, filed 17 Feb 2015.